{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T23:48:51Z","timestamp":1649029731857},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Inspirion Delivery Sciences, LLC.","award":["1"],"award-info":[{"award-number":["1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s12325-019-01022-4","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T15:02:50Z","timestamp":1562338970000},"page":"2394-2401","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond\u2122 ER), an Abuse-Deterrent Formulation of Extended-Release Morphine"],"prefix":"10.1007","volume":"36","author":[{"given":"Eric R.","family":"Kinzler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Pantaleon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Iverson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"key":"1022_CR1","unstructured":"Centers for Disease Control and Prevention. National vital statistics reports rapid release: provisional drug overdose death counts for 2017. 2018. \n                    https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm\n                    \n                  . Accessed 24 Aug 2018."},{"key":"1022_CR2","first-page":"412","volume":"37","author":"R Moorman-Li","year":"2012","unstructured":"Moorman-Li R, Motycka CA, Inge LD, et al. A review of abuse-deterrent opioids for chronic nonmalignant pain. P T. 2012;37:412\u20138.","journal-title":"P T."},{"key":"1022_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/00952990.2011.569623","volume":"37","author":"N Katz","year":"2011","unstructured":"Katz N, Dart RC, Bailey E, et al. Tampering with prescription opioids: nature and extent of the problem, health consequences, and solutions. Am J Drug Alcohol Abuse. 2011;37:205\u201317.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"1022_CR4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1080\/03007995.2017.1419171","volume":"34","author":"JV Pergolizzi Jr","year":"2018","unstructured":"Pergolizzi JV Jr, Raffa RB, Taylor R Jr, et al. Abuse-deterrent opioids: an update on current approaches and considerations. Curr Med Res Opin. 2018;34:711\u201323.","journal-title":"Curr Med Res Opin"},{"key":"1022_CR5","unstructured":"MorphaBond ER (morphine sulfate) extended-release tablets [prescribing information]. Basking Ridge, NJ: Daiichi Sankyo, Inc.; September 2018. 2018. \n                    https:\/\/morphabondhcp.com\/prescribing-information-portlet\/getDocument?product=MB&inline=true\n                    \n                  . Accessed 24 Oct 2018."},{"key":"1022_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2165\/00003088-199937030-00003","volume":"37","author":"BN Singh","year":"1999","unstructured":"Singh BN. Effects of food on clinical pharmacokinetics. Clin Pharmacokinet. 1999;37:213\u201355.","journal-title":"Clin Pharmacokinet"},{"key":"1022_CR7","unstructured":"FDA briefing document (Avridi), Joint Meeting of Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee, September 10, 2015. \n                    https:\/\/www.fdanews.com\/ext\/resources\/files\/09-15\/9-15-FDA-Briefing.pdf?1520642200\n                    \n                  . Accessed 24 Oct 2018."},{"key":"1022_CR8","unstructured":"FDA briefing document (Xtampza ER), Joint Meeting of Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee, September 11, 2015. \n                    https:\/\/www.pharmamedtechbi.com\/~\/media\/Supporting%20Documents\/The%20Pink%20Sheet%20DAILY\/2015\/September\/Collegium_oxycodone_AC_company_brfg.pdf\n                    \n                  . Accessed 24 Oct 2018."},{"key":"1022_CR9","unstructured":"Xtampza ER (oxycodone) extended-release capsules [prescribing information]. Stoughton, MA: Collegium Pharmaceuticals, Inc; September 2018. 2018 \n                    http:\/\/www.xtampzaer.com\/assets\/pdf\/xtampza-pi.pdf\n                    \n                  ."},{"key":"1022_CR10","unstructured":"Naltrexone hydrochloride tablets USP [prescribing information]. Webster Groves, MO: Mallinckrodt Pharmaceuticals; July 2017. 2017. \n                    https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/018932s017lbl.pdf\n                    \n                  . Accessed 24 Oct 2018."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01022-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-019-01022-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01022-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T23:06:19Z","timestamp":1593817579000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-019-01022-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,5]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1022"],"URL":"https:\/\/doi.org\/10.1007\/s12325-019-01022-4","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,5]]},"assertion":[{"value":"16 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}